Non-ownership Filings
| Imfinzi approved in US for early gastric cancer | Nov. 26, 2025 |
| AstraZeneca manufacturing investment in Maryland | Nov. 24, 2025 |
| Koselugo (selumetinib) approved in the US | Nov. 20, 2025 |
| Holding(s) in Company | Nov. 17, 2025 |
| Director Declaration | Oct. 28, 2025 |
| Koselugo (selumetinib) approved in the EU | Oct. 28, 2025 |
| Tezspire Approved in EU for CRSwNP | Oct. 22, 2025 |
Ownership Update Filings
| Director/PDMR Shareholding | Nov. 14, 2025 |
| Director/PDMR Shareholding | Nov. 10, 2025 |
| Director/PDMR Shareholding | Sep. 25, 2025 |
| Holding(s) in Company | Aug. 28, 2025 |
| Holding(s) in Company | Aug. 26, 2025 |
| Holding(s) in Company | Aug. 21, 2025 |
| Director/PDMR Shareholding | Aug. 18, 2025 |